ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
14 announcements with these filters
Camlin Fine Sciences filed a Postal Ballot Notice seeking approval to appoint Mr. Atul Pradhan as Non-Executive Independent Director. E-voting runs September 17 to October 16, 2026.
Camlin Fine Sciences appointed Mr. Atul Pradhan as Additional Non-Executive Independent Director effective September 11, 2026. The appointment is subject to shareholder approval via postal ballot.
Camlin Fine Sciences reported Q1 FY27 revenue of INR 5,199 million, up 28% YoY, though EBITDA margins were pressured to 4% by high raw material and freight costs.
Camlin Fine Sciences reported record quarterly revenue of Rs 5,199 Mn for Q1FY27, up 27.5% YoY, driven by strong growth in Specialty Ingredients and Aroma segments.
Camlin Fine Sciences Ltd reported revenue from operations of ₹519.9 Cr (+27.5% YoY) and a net loss of ₹33.6 Cr for Q1 FY27.
Camlin Fine Sciences Limited held its 33rd Annual General Meeting on August 11, 2026. All resolutions proposed in the notice were passed by the shareholders.
Camlin Fine Sciences Limited will hold a board meeting on August 11, 2026. The board will consider and approve un-audited financial results for the quarter ended June 2026.
Promoter Ashish Subhash Dandekar released a pledge of 4,000 equity shares of Camlin Fine Sciences Ltd. This release followed the repayment of borrowings by the company.
Camlin Fine Sciences informed shareholders about the upcoming 33rd Annual General Meeting and the availability of the Annual Report 2025-26 on its website.
Camlin Fine Sciences Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26.
Camlin Fine Sciences Ltd has issued a notice for its 33rd Annual General Meeting scheduled for August 11, 2026, to be held via video conferencing.
Camlin Fine Sciences Ltd has filed its Annual Report for the financial year 2025-26. The 33rd AGM is scheduled for August 11, 2026.
Camlin Fine Sciences completed a cash tender offer acquiring the remaining Vinpai shares, raising its holding to 95.41%. No financial amount is disclosed.
Camlin Fine Sciences announced the resignation of VP R&D Mr. Anvarhusen Bilakhiya, effective July 7, 2026. His departure follows a personal commitment, as per his resignation letter.